Rate My Professor Stewart Dunn

Dunn's clinical specialty is psycho-oncology, where he works with cancer patients and their families. His research specializations include the psychology of medical illness, doctor-patient communication, psycho-oncology, and related areas such as diabetes, asthma, and multiple sclerosis. His scholarly impact is significant, with his research ranked in the top 2% internationally by Stanford University in 2022 and recognized among the University of Sydney's global elite researchers. He has authored over 132 publications, accumulating more than 10,000 citations. Notable publications include 'eFOCUS 2: A randomised crossover trial of smartphone fundoscopy and direct ophthalmoscopy aiming to improve optic disc interpretation by medical students with e-learning support' (2021), 'Psychological and Medical Characteristics Associated with Non-Adherence to Prescribed Daily Inhaled Corticosteroid' (2020), 'The impact of delivery style on doctors' experience of stress during simulated bad news consultations' (2015), and 'The Australian Multicenter Trial of Growth Hormone (GH) Treatment in GH Deficient Adults: Changes in Body Composition and Serum Biochemistry' (1998). His work has influenced medical education, patient care, and interprofessional learning.